{
    "Trade/Device Name(s)": [
        "Anyplex\u2122 II HSV-1/2 Assay",
        "AnyplexTM II HSV-1/2 Assay"
    ],
    "Submitter Information": "Seegene",
    "510(k) Number": "K142156",
    "Predicate Device Reference 510(k) Number(s)": [
        "K140198"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OQO"
    ],
    "Summary Letter Date": "February 10, 2015",
    "Summary Letter Received Date": "February 11, 2015",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes Simplex Virus Nucleic Acid Amplification Assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Herpes Simplex Virus Type-1 (HSV-1) DNA",
        "Herpes Simplex Virus Type-2 (HSV-2) DNA"
    ],
    "Specimen Type(s)": [
        "Female skin lesions from anogenital sites"
    ],
    "Specimen Container(s)": [
        "Viral transport media (M4)"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid SmartCycler\u00ae II Dx"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time polymerase chain reaction (PCR)",
        "Fluorescently-labeled oligonucleotide probes (duplex Catcher)"
    ],
    "Methodologies": [
        "RT-PCR",
        "DNA amplification",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Kit",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Seegene Anyplex II HSV-1/2 real-time PCR assay for qualitative detection and differentiation of HSV-1 and HSV-2 DNA in female anogenital lesion specimens",
    "Indications for Use Summary": "A real-time PCR assay for qualitative detection and differentiation of HSV-1 and HSV-2 DNA from female anogenital skin lesion specimens, as an aid in diagnosis of anogenital HSV infection in symptomatic patients",
    "fda_folder": "Microbiology"
}